Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2025-12-24 @ 4:57 PM
NCT ID:
NCT00872950
Eligibility Criteria:
Inclusion Criteria:
* LEMS diagnosis OR Pre or Post Synaptic CMS diagnosis
* 18 years or older
* Females must have negative pregnancy test and be willing to practice an effective form of birth control
* No prolonged QT syndrome as indicated by baseline EKG
Exclusion Criteria:
* Known sensitivity to 3,4-DIAMINOPYRIDINE
* History of seizures and/or severe asthma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00872950
Study Brief:
Protocol Section:
NCT00872950